Chapple Reprint
A review of male lower urinary tract symptoms with a focus on the bladder and OAB, including a discussion of underlying conditions, the role of bladder dysfunction, and pharmacotherapeutic options.
A review of male lower urinary tract symptoms with a focus on the bladder and OAB, including a discussion of underlying conditions, the role of bladder dysfunction, and pharmacotherapeutic options.
Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder
A 12-Week, randomized, double-blind, placebo- and active-controlled trial to assess the efficacy and safety of fesoterodine 4 mg and 8 mg extended-release tablets.
A 12-Week, randomized, double-blind, placebo- and active-controlled trial to assess the efficacy and safety of fesoterodine 4 mg and 8 mg extended-release tablets.
Efficacy and safety of sildenafil citrate (Viagra® (sildenafil citrate) tablets) in men with erectile dysfunction and spinal cord injury: a review (Derry et al, 2002)
Review of 2 randomized controlled trials and 4 prospective case study series evaluating safety and efficacy of sildenafil citrate in men with erectile dysfunction and spinal cord injury.
Review of 2 randomized controlled trials and 4 prospective case study series evaluating safety and efficacy of sildenafil citrate in men with erectile dysfunction and spinal cord injury.
Efficacy, Safety and Tolerability of Fesoterodine for Overactive Bladder Syndrome
A 12-week, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of fesoterodine 4-mg and 8-mg extended-release tablets.
A 12-week, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of fesoterodine 4-mg and 8-mg extended-release tablets.
Elinoff Reprint
A 12-week, single-arm, open-label study that evaluated the efficacy of tolterodine tartrate extended-release capsules (4 mg qd) in 863 adult patients with overactive bladder (OAB) symptoms.
A 12-week, single-arm, open-label study that evaluated the efficacy of tolterodine tartrate extended-release capsules (4 mg qd) in 863 adult patients with overactive bladder (OAB) symptoms.
Erectile dysfunction and subsequent cardiovascular disease (Thompson et al, 2005)
An analysis of men who were randomized to the placebo group in the Prostate Cancer Prevention Trial to examine the association of erectile dysfunction and subsequent cardiovascular disease.
An analysis of men who were randomized to the placebo group in the Prostate Cancer Prevention Trial to examine the association of erectile dysfunction and subsequent cardiovascular disease.
Erectile dysfunction: Monitoring response to treatment in clinical practice—recommendations of an international study panel (Mulhall et al, 2007)
In order to provide evidence-based treatment goals for erectile dysfunction (ED), an international panel of urologists, primary care physicians, and psychologists analyzed retrospective data from a variety of trials involving sildenafil citrate.
In order to provide evidence-based treatment goals for erectile dysfunction (ED), an international panel of urologists, primary care physicians, and psychologists analyzed retrospective data from a variety of trials involving sildenafil citrate.
Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction (Mulhall et al, 2006)
Extensive sildenafil citrate erectile dysfunction (ED) database of double-blind, placebo-controlled clinical trials was examined to determine the effect of treatment on erectile function.
Extensive sildenafil citrate erectile dysfunction (ED) database of double-blind, placebo-controlled clinical trials was examined to determine the effect of treatment on erectile function.
Freeman Reprint
A 12-week randomized study that compared the effect of tolterodine tartrate extended release capsules (4 mg qd) on urinary urgency vs placebo in 772 adult patients with OAB.
A 12-week randomized study that compared the effect of tolterodine tartrate extended release capsules (4 mg qd) on urinary urgency vs placebo in 772 adult patients with OAB.
Kaplan Reprint - Times Study
A 12-week randomized, double-blind placebo-controlled trial that evaluated the efficacy and safety of tolterodine tartrate extended release capsules (4 mg qd), tamsulosin (0.4 mg qd), or both in men ?40 years with a dual diagnosis of OAB and BPH.
A 12-week randomized, double-blind placebo-controlled trial that evaluated the efficacy and safety of tolterodine tartrate extended release capsules (4 mg qd), tamsulosin (0.4 mg qd), or both in men ?40 years with a dual diagnosis of OAB and BPH.
Landis Reprint
A post hoc subgroup analysis of 986 patients from the Registration Study that compared the efficacy of tolterodine tartrate capsules (4 mg qd) with placebo in severe urgency incontinence.
A post hoc subgroup analysis of 986 patients from the Registration Study that compared the efficacy of tolterodine tartrate capsules (4 mg qd) with placebo in severe urgency incontinence.
Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. (Raina et al, 2003)
An open label study to evaluate the long-term effect and safety of sildenafil citrate for the treatment of erectile dysfunction after radical prostatectomy.
An open label study to evaluate the long-term effect and safety of sildenafil citrate for the treatment of erectile dysfunction after radical prostatectomy.
Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate (Raina et al, 2003)
Prospective study to assess long-term sexual function after iodine-125 (I-125) seed radiotherapy and the effect of sildenafil on radiation-induced erectile dysfunction (ED).
Prospective study to assess long-term sexual function after iodine-125 (I-125) seed radiotherapy and the effect of sildenafil on radiation-induced erectile dysfunction (ED).
Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial (Padma-Nathan et al, 2003)
Randomized, double-blind, placebo-controlled trial to determine minimal time to successful intercourse after treatment with sildenafil citrate.
Randomized, double-blind, placebo-controlled trial to determine minimal time to successful intercourse after treatment with sildenafil citrate.
Oral sildenafil in the treatment of erectile dysfunction (Goldstein et al, 1998)
This analysis evaluated the efficacy and safety of sildenafil, administered as needed in 2 sequential double-blind studies of men with ED of organic, psychogenic, and mixed causes.
This analysis evaluated the efficacy and safety of sildenafil, administered as needed in 2 sequential double-blind studies of men with ED of organic, psychogenic, and mixed causes.
Roberts Reprint
A 12-week, single-arm, open-label study that evaluated the effect of tolterodine tartrate extended-release capsules (4 mg qd) on patient- and clinician-reported outcomes in 863 adults with OAB symptoms.
A 12-week, single-arm, open-label study that evaluated the effect of tolterodine tartrate extended-release capsules (4 mg qd) on patient- and clinician-reported outcomes in 863 adults with OAB symptoms.
Siami Reprint
A 12-week, open-label, multicenter trial that assessed the speed of onset of therapeutic benefit with tolterodine tartrate capsules (4 mg qd) in 1138 patients with overactive bladder.
A 12-week, open-label, multicenter trial that assessed the speed of onset of therapeutic benefit with tolterodine tartrate capsules (4 mg qd) in 1138 patients with overactive bladder.
Sildenafil citrate (Viagra® (sildenafil citrate) tablets) treatment for erectile dysfunction: An updated profile of response and effectiveness (Padma-Nathan et al, 2006)
This update provides data on sildenafil efficacy and safety/tolerability, as well as assessments of erection hardness and treatment approaches to maximize response and effectiveness.
This update provides data on sildenafil efficacy and safety/tolerability, as well as assessments of erection hardness and treatment approaches to maximize response and effectiveness.
The efficacy of sildenafil citrate (Viagra® (sildenafil citrate) tablets) in clinical populations: an update (Carson et al, 2002)
Examines results from randomized trials of sildenafil citrate (VIAGRA) across various subgroups of men with ED.
Examines results from randomized trials of sildenafil citrate (VIAGRA) across various subgroups of men with ED.
Van Kerrebroeck Reprint
A 12-week, randomized, double-blind, placebo-controlled, multicenter trial that compared the efficacy and safety of tolterodine tartrate capsules (4 mg qd) and tolterodine tartrate tablets (2 mg bid) with placebo in 1529 adults with urinary frequency and urgency incontinence.
A 12-week, randomized, double-blind, placebo-controlled, multicenter trial that compared the efficacy and safety of tolterodine tartrate capsules (4 mg qd) and tolterodine tartrate tablets (2 mg bid) with placebo in 1529 adults with urinary frequency and urgency incontinence.
Zinner Reprint
A 12-week, double-blind, placebo-controlled trial that evaluated the efficacy, safety, and tolerability of tolterodine tartrate extended release capsules (4 mg qd) in a total of 1015 older (?65) vs younger (<65) patients
A 12-week, double-blind, placebo-controlled trial that evaluated the efficacy, safety, and tolerability of tolterodine tartrate extended release capsules (4 mg qd) in a total of 1015 older (?65) vs younger (<65) patients
